Archive


Category: MedTech

  • Hologic to Acquire Bolder Surgical for $160M

    Shots: Hologic to acquire Bolder Surgical for ~$160M which is a provider of advanced energy vessel sealing surgical devices. The acquisition is expected to be closed by 2021 The transaction will add laparoscopic vessel sealing, dividing and dissecting devices to the Hologic portfolio and enable it to expand the use of Bolder’s devices to OB/GYN specialists The […]

  • Medtronic’s Radial Artery Catheter Device Receives CE Mark Approval for the Treatment of Neurovascular Diseases

    Shots: The company has received CE Mark for its radial artery access portfolio including Rist 079 radial access guide catheter and Rist radial access selective catheter to treat patients with stroke, brain aneurysms & other neurovascular conditions Additionally, both device is designed to introduce interventional devices into peripheral, coronary & neuro vasculature. The devices are […]

  • GE Healthcare to Acquire BK Medical for ~ $1.45B

    Shots: GE has signed an agreement to acquire BK Medical for $1.45B in cash and is eligible to receive a high-single-digit return on invested capital within 5yrs. The transaction is expected to close in 2022 The acquisition will allow GE Healthcare to expand its $3B ultrasound business from diagnostics into surgical & therapeutic interventions. The […]

  • Abbott’s Epic Plus Tissue Valves Receives the US FDA’s Approval for the Treatment of Mitral or Aortic Valve Replacement

    Shots: The US FDA has approved Abbott’s Epic Plus & Epic Plus Supra Stented Tissue valves to treat patients with aortic or MV disease who undergoes valve replacement surgery. The devices build off Abbott’s Epic surgical valve platform Abbott’s Epic valve including radiopaque markers helps to improve implantation & allows compatibility for future transcatheter valve […]

  • Brain data startup Rune Labs reveals $23M, plans to rev up neuro drug R&D

    Rune Labs developed software that aggregates brain data, providing insights for clinical care and clinical research. Health systems are starting to adopt the technology, and the startup has now raised $22.8 million to grow that part of the business while also expanding use of the technology in drug development.

  • ZOLL to Acquire Itamar for ~$538M

    Shots: ZOLL Medical to acquire all outstanding ordinary shares of Itamar Medical for $31/ADS or $1.03/ordinary share in cash making a total deal value of $538M representing a premium of 50.2% for $31/ADS to the stock’s last closing price on Sept 10, 2021. The transaction is expected to close at the end of 2021 The […]

  • Abbott to Acquire Walk Vascular to Bolster its Peripheral Vascular Offerings

    Shots: The acquisition will accelerate Abbott’s vascular portfolio with the addition of Walk Vascular’s peripheral thrombectomy systems to treat patients with peripheral blood clots Walk Vascular’s JETi & JETi AIO peripheral thrombectomy systems are aspiration systems for the removal of intravascular clots. The systems are supported by RWE, and Walk is currently enrolling ~250 patients […]

  • Abiomed’s Impella ECP; Helius’s PoNS Device; Smart Meter’s iGlucose BGM; XACT’s CT-Guided Percutaneous Procedures; BD’s Veritor At-Home COVID-19 Test; Delfi’s Liquid Biopsy

    FDA awards Breakthrough Device Designation to Impella ECP  On August 18, 2021, Abiomed received breakthrough device designation from the United States Food and Drug Administration (FDA) for its Impella ECP expandable percutaneous heart pump, the world’s smallest heart pump and the first to be compatible with small-bore access and closure techniques.   This designation was based […]

  • Abbott Reports Head-to-Head Data for Amplatzer Amulet Against Boston Scientific’s Watchman Device to Treat Atrial Fibrillation #ESC2021

    Shots: The head-to-head Amulet IDE study compares Amplatzer Amulet Left Atrial Appendage (LAA) Occluder with the Watchman device to treat patients with AFib at an increased risk of stroke The study demonstrated superiority for the 1EPs of LAA (98.9% vs 96.8%) and was non-inferior for the co-primary safety & effectiveness endpoints Abbott’s Amulet Occluder with […]

  • Boston Scientific’s EkoSonic; FDA clearance for EXALT; Kestra Medical’s ASSURE; ZOLL Next-Generation remedē system; CytoSorbents’ DrugSorb-ATR; Fujifilm-Lunit collaboration

    Boston Scientific starts recruitment for randomized controlled trials for the EkoSonic Endovascular System On August 04, 2021, Boston Scientific Corporation started the enrolment in the HI-PEITHO clinical trial, which is a collaborative research study with the Pulmonary Embolism Response Team (PERT) Consortium and the University Medical Center of the Johannes Gutenberg University of Mainz comparing […]

  • Verily Acquires SignalPath to Expand its Clinical Research Capabilities

    Shots: The acquisition will bolster Verily’s clinical trial system and Baseline platform to improve the efficiency, costs in clinical trials & speed up it at research sites globally. It also collects patient data for site-based, hybrid, and decentralized clinical studies SignalPath’s platform leverages modern software architecture with a cloud-based platform to reduces fragmentation & advance […]

  • Medtronic to Acquire Intersect ENT for ~$1.1B

    Shots: Medtronic to acquire all outstanding shares of Intersect ENT for $28.25/ share in cash, making a total deal value of ~$1.1B. The transaction is expected to be completed by H1’22 The acquisition will expand Medtronic’s product portfolio which is used in the ENT procedure. Additionally, the acquisition will add a bioabsorbable drug release platform […]

  • Abbott Launches Jot Dx Insertable Cardiac Monitor to Detect Abnormal Heart Rhythms in US

    Shots: Abbott launches its latest Jot Dx ICM with new features to help clinicians for a constant flow of heart rhythm data to treat atrial fibrillation Jot Dx ICM allows 24/7 heart monitoring and connects directly with Abbott’s myMerlin smartphone app. The technology is designed to provide remote detection and improved diagnostic accuracy of cardiac […]

  • BD Acquires Tepha to Boost its Surgical Mesh Portfolio

    Shots: The acquisition will utilize Tepha’s resorbable polymer technology to boost the growth of BD’s surgical mesh portfolio for the repair and regeneration of soft tissues The acquisition also provides strategic vertical integration for BD’s Phasix mesh products & includes Tepha’s GalaFLEX portfolio which is based on the novel P4HB polymer Additionally, an interventional segment […]

  • Hologic Receives CE Mark to Use Saliva Samples with Aptima SARS-CoV-2 Test in EU

    Shots: The company has received a CE Mark for the use of saliva samples with the Aptima SARS-CoV-2 assay in the EU. The test runs on the fully automated Panther system The Aptima SARS-CoV-2 assay also received a CE Mark for nasopharyngeal and nasal swabs along with additional specimen types The company has broadened the […]

  • QIAGEN Collaborates with Mirati to Develop KRASG12C CDx for Non-Small Cell Lung Cancer

    Shots: The companies collaborated to develop a tissue based KRAS Cdx test to identify patients with cancers that have a KRASG12C mutation who may benefit from treatment with adagrasib, which is an investigational small molecule inhibitor of KRASG12 The agreement initially focuses on developing CDx for NSCLC and allows to further development of tests for […]

  • Glaukos Expands its Partnership with Santen for Preserflo MicroShunt

    Shots: The companies enter into a license agreement for the Preserflo MicroShunt superseding the previous collaboration between the two parties Glaukos get exclusive commercialization rights for the MicroShunt in the US, Australia, New Zealand, Canada, Brazil, Mexico and the remainder of Latin America and gain full control over all development activities for the MicroShunt in […]

  • Roche Receives the US FDA’s EUA for cobas SARS-CoV-2 Test to Suspect COVID-19

    Shots: Roche’s cobas SARS-CoV-2 test to be use on high-throughput cobas 6800/8800 systems has received the US FDA’s EUA for testing individuals without symptoms or reasons to control the spread of COVID-19 The authorization expands SARS-CoV-2 testing to include people without symptoms and applies to pooled samples containing up to and including 6 individual samples […]

  • PerkinElmer to Acquire Immunodiagnostic Systems Holdings for ~$155M

    Shots: PerkinElmer to acquire IDS in all cash transactions for ~$155M. The transaction is expected to be completed in Q3’21 The acquisition will allow PerkinElmer to foster its overall Diagnostics business and specifically its immunodiagnostics segment The acquisition will integrate PerkinElmer’s channel expertise and testing capabilities with IDS’ chemiluminescence products in endocrinology, autoimmunity, and infectious […]

  • Medtronic Launches SonarMed Airway Monitoring System to Detect Airway Obstruction During Ventilation in Pediatric Patients

    Shots: The company launches SonarMed airway monitoring system to detect ETT obstruction and confirms the real-time position by using acoustic technology and provides immediate, actionable intelligence for clinicians The SonarMed airway monitoring system is the first and only FDA-cleared airway monitoring system that helps to reduce the frequency of UEs, thus improve outcomes and reduce […]

  • Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M

    Shots: Soliton to receive $22.60 /share in cash for its all outstanding share making the total deal value $550M The acquisition adds Soliton’s Rapid Acoustic Pulse technology platform to Allergan Aesthetics’s portfolio for improvement in appearance of cellulite in the buttocks and thighs by using rapid high-frequency sound waves to disrupt targeted cellular structures and […]

  • BD to Spin Off its Diabetes Care Business into New Public Company

    Shots: The spin-off of the Diabetes Care business will allow the BD to strengthen its growth profile, enables it to focus on its other core businesses. The transaction is expected to be completed in H1’22 Standalone Diabetes Care business is expected to leverage its position as a global leader in insulin delivery and expand its […]

  • BMS Signs a Research Collaboration with DarwinHealth to Discover Novel Cancer Target Initiative

    Shots: DarwinHealth will receive an upfront and eligible to receive as a commercial milestone, as part of the NCTI collaboration The focus of the collaboration is to identify NCTs across tumor subtypes for different cancer types by using quantitative systems biology-based algorithms, databases, and technologies and leads to the development of drugs with multi-subtype indications […]

  • Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

    Shots: The Phenomix’s MyPhenome test utilize phenotype-driven multi-omics technology to analyze genomics, metabolomics, and hormone levels and use AI-driven algorithmic tool to identify four specific obesity phenotypes, giving doctors the ability to prescribe more precise anti-obesity treatments The study showed that phenotype-specific obesity resulted in nearly double the weight loss over the treatment course of […]

  • Labcorp to Acquire Myriad’s Vectra Testing Business for $150M

    Shots: Labcorb acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21 The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfolios Vectra is a non-invasive, blood-based test that analyzes […]

  • Labcorp to Acquire Myriad’s Vectra Testing Business for $150M

    Shots: Labcorb acquires the Vectra RA test from Myriad Genetics along with other operating assets and IP for $150M in cash. The transaction is expected to close in Q3’21 The divestiture of Myriad auto immune’s Vectra testing business allow Labcorb to bolster its rheumatology and autoimmune portfolios Vectra is a non-invasive, blood-based test that analyzes […]

  • Abbott Launches AI-Powered Coronary Imaging Platform in Europe

    Shots: Abbott’s new imaging platform powered by Ultreon 1.0 software has received a CE mark in the EU. The new imaging platform merges optical coherence tomography (OCT) with AI to enhance visualization and detect the severity of calcium-based blockages and measure vessel diameter Ultreon software when integrated with Abbott’s new Dragonfly OpStar imaging catheter allows […]

  • Medtronic Collaborates with Surgical Theater to Provide Augmented Reality Platform to Neurosurgery

    Shots: The companies collaborated Surgical Theater’s SyncAR augmented reality (AR) technology with Medtronic’s StealthStation S8 surgical navigation system The collaboration will allow neurosurgeons to use AR technology in real-time to visualize structures in the brain, test virtual surgical tools and plan surgeries before entering the operating room Integration of SyncAR into the StealthStation S8 cranial […]

  • Janssen Collaborates with PhysIQ for Wearable Biosensors and Digital Biomarkers Initiatives

    Shots: Janssen gets license to utilize physIQ’s accelerateIQ platform to gather data from clinical studies through different wearable biosensors. The platform is powered by FDA-cleared digital biomarkers that helps to transform raw data into clinical insight The platform’s findings can be used to advance subsequent research projects and will support both R&D and commercial strategies […]

  • ThermoFisher to Acquire PPD for ~$17.4B

    Shots: ThermoFisher to acquire PPD for $47.50/share making a total purchase price of $17.4B along with ~$3.5B of net debt with a premium of ~24% to the closing price of PPD’s common stock as of Apr 13, 2021. The transaction is expected to be completed by the end of 2021 The acquisition expands ThermoFisher’s service […]

  • Roche and Biocorp Launch Mallya Smart Insulin Pen for Patients with Diabetes in France

    Shots: The companies launched the Mallya smart insulin pen device in France to support patients with diabetes. The smart insulin pen is available in pharmacies and is compatible with any disposable insulin pens The device collects and transfers insulin data with 100% accuracy and is rechargeable via its USB port. Mallya automatically collects insulin data […]

  • Avantor to Acquire Ritter and its Affiliates for ~$1.06B

    Shots: Avantor to acquire Ritter and its affiliates in an all-cash transaction with an up front equity purchase price of ~ $1.06B along with additional payments following the achievement of milestones. The transaction is expected to be completed in Q3’21 The acquisition expands Avantor’s offering for diagnostic and drug discovery workflows The acquisition integrates Ritter’s […]

  • DiaSorin to Acquire Luminex for ~$1.8B

    Shots: DiaSorin to acquire Luminex for $37.00/ share in an all-cash transaction, with 23% premium based on closing stock price of Luminex on 24 Feb, 2021, making a total equity value of $1.8B The acquisition will boost DiaSorin’s presence in the molecular diagnostics space in the US with the addition of Luminex’s molecular diagnostics multiplexing […]

  • Hologic to Acquire Mobidiag for ~ $795M

    Shots: Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21 The acquisition will accelerate Hologic’s global footprints by enabling it to expand into the large, fast-growing acute care adjacency with a near-patient testing solution that offers ease of […]

  • Medtronic’s Harmony Transcatheter Pulmonary Valve Receives the US FDA’s Approval for Patients with Congenital Heart Disease

    Shots: The approval is based on clinical data from the Harmony TPV clinical study that showed freedom from mortality & acceptable hemodynamic function @30days & 6mos. respectively The study demonstrated that patients treated with Harmony TPV experienced no significant reinterventions, reoperations or endocarditis @6mos. Harmony TPV is the first minimally invasive alternative for patients with […]

  • Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

    Shots: Immunai acquires the Dropprint Genomics and also expand its team with the hiring of new experts in immunology, single-cell technologies and machine learning The acquisition and the new hiring will advance the Immunai’s work in single cell functional genomics to support discovery, prioritization, and development of new therapies and drug combinations The acquisition happened […]

  • Roche Launches New Configurations for Cobas Pro to Increase Testing Efficiency

    Shots: Roche launches eight new configurations for Cobas pro integrated solutions in countries accepting the CE mark and is designed to address the individual needs to maximize throughput and efficiency Cobas pro integrated solutions can deliver up to 4,400 tests/ hr., doubling its previous testing capacity. The addition of the new configurations allows labs to […]

  • Roche Launches Cobas SARS-CoV-2 Variant Test to Detect Emerging Coronavirus Mutations

    Shots: The company has launched the cobas SARS-CoV-2 variant set 1 test to detect spike mutations in virus variants including UK (B.1.1.7), South Africa (B.1.351), and Brazil (P.1) The accurate detection and differentiation of SARS-CoV-2 mutations can aid in assessing the spread of circulating variants and monitor their potential impact on diagnostics, vaccines and therapeutics […]

  • Cardinal Health to Divest its Cordis Business to Hellman & Friedman for $1B

    Shots: Cardinal Health signed an agreement to divest its Cordis medical device business to H&F for ~ $1B including liabilities and working capital accounts. The transaction is expected to close in the H1’ 22 Following the completion of the agreement, H&F will assume most of the Cordis assets and liabilities while Cardinal Health will retain […]

  • Abbott Launches Pandemic Defense Coalition to Detect Future Threats

    Shots: The coalition builds on Abbott’s excellence in virus surveillance and aid in analyzing virus samples for unknown diseases and detects mutations and variants including COVID-19 The goal of the Pandemic Defense Coalition is to identify new pathogens, analyze potential risk level, assess public health impact in real-time, and contain outbreaks when new virus threats […]

  • Abbott Launches NeuroSphere Virtual Clinic for Remote Neurostim Programming in the US

    Shots: The US FDA has approved NeuroSphere Virtual Clinic that allows a patient to communicate with a physician and remotely receive stimulation settings in real time regardless of location NeuroSphere Virtual Clinic allows clinicians to provide new treatment settings remotely to the patient’s neurostimulation device using the clinician programmer app The virtual clinic is compatible […]

  • TrinamiX Signs a Joint Development Agreement with VIAVI Solutions to Bring Near-Infrared Spectroscopy into Smartphones

    Shots: The companies collaborated to bring a Near-Infrared (NIR) spectrometer module for integration into consumer devices The collaboration will integrate both the companies’ expertise to lift today’s smartphone capabilities to the next level The new functionality in the smartphones will enable consumers to easily scan their skin on a molecular level to receive near-instantaneous suggestions […]

  • Agilent to Acquire Resolution Bioscience for $695M

    Shots: Resolution to receive $550M in cash at closing and ~$145M following the achievement of certain milestones. The transaction is expected to close in Apr’2021 The acquisition will expand Agilent’s capabilities in NGS-based cancer diagnostics and strengthen its position in precision oncology testing globally The acquisition will bring together Resolution’s noninvasive liquid biopsy platform that […]

  • Boston Scientific Signs an Agreement with BPEA to Acquire Lumenis’ Surgical Business

    Shots: Boston Scientific to acquire the global surgical business of Lumenis for $1.07B as an up front in cash. The transaction is expected to be completed in H2’21 BPEA will retain ownership of the Lumenis global aesthetics and ophthalmology businesses. The acquisition will expand Boston Scientific’s global kidney stone management portfolio and will expand its […]

  • Hologic to Acquire Diagenode for ~$159M

    Shots: Hologic to acquire Diagenode for ~$159M. The transaction will expand and diversifies Hologic’s diagnostic business across test menu, customer segments and geography The acquisition will strengthen Hologic’s molecular diagnostics business by expanding international its capabilities and allow it to offer a broader more differentiated test menu Diagenode and Hologic previously collaborated to develop Hologic’s […]

  • Lilly to Integrate its Digital Insulin Pen with Welldoc’s BlueStar App

    Shots: The companies collaborated to get a new version of the BlueStar insulin management app that integrates insulin dosing data for several of Lilly’s insulins If approved, Lilly plans to commercialize the initial pen platform in the US and will evaluate opportunities to launch it in other geographies while Welldoc will continue to separately commercialize […]

  • Otsuka and Click Initiate Digital Study in Adults with Major Depressive Disorder

    Shots: Otsuka and Click have reported the initiation of the Mirai study which is a fully remote clinical trial to investigate the effectiveness of digital therapeutics in reducing depressive symptoms in adults diagnosed with MDD who are on antidepressant monotherapy. The study will enroll ~540 patients globally The trial will run fully remotely utilizing the […]

  • Qiagen Expand its Collaboration with Inovio to Develop Liquid Biopsy Based CDx for VGX-3100 to Treat Advanced Cervical Dysplasia

    Shots: The companies collaborated to develop liquid biopsy-based CDx based on NGS technology to complement Inovio’s therapies. The collaboration initially focuses on the co-development of a diagnostic test that identifies women who are most likely to benefit from VGX-3100 QIAGEN’s bioinformatic expertise will raise the predictive biomarker power in Inovio’s patient selection. The assay will […]

  • Medidata Launches Sensor Cloud to Connect Device and Wearables in Clinical Trials

    Shots: The company launches Sensor Cloud for managing sensor and digital health technology data during the clinical trial. Sensor Cloud integrates with Medidata Rave Clinical Cloud and supports continuous patient data collection from both Medidata and third-party medical-grade sensors The launch of Sensor Cloud strengthens Medidata’s unique data ingestion, analytics & insights capabilities, providing differentiated […]

  • Hologic Collaborate with Google Cloud to Advance Screening in Cervical Cancer

    Shots: The companies collaborated to integrate Google Cloud’s ML technologies with Hologic’s Genius Digital Diagnostics System to transform screening and accelerate the eradication of cervical cancer across the globe The alliance promises to migrate the system’s data management infrastructure to the cloud, and the two companies will also work to further develop its deep learning […]

  • Roche’s Elecsys GDF-15 Assay Receives the US FDA’s Breakthrough Device Designation as a CDX in Cancer Treatment

    Shots: The US FDA grants the BDD for Elecsys GDF-15 assay that is intended for measurement of Growth Differentiation Factor-15 (GDF-15) in cachectic patients aged≥18yrs. with solid tumors for treatment with Pfizer’s PF-06946860 GDF-15 assay helps to identify patients suitable for innovative treatment addressing unintentional weight loss in cancer patients and may provide a precision […]

  • Roche Collaborate with Cambridge Quantum Computing to Develop Quantum Algorithm for Drug Discovery and Development

    Shots: CQC collaborates with Roche to design and implement noisy-intermediate-scale-quantum (NISQ) algorithms for early-stage drug discovery and development The collaboration will employ CQC’s quantum chemistry platform ‘EUMEN’, to augment the Roche’s AD research efforts The multi-year collaboration will combine the expertise of both CQC and Roche to advance the application of quantum computing to pharmaceutical […]

  • Abbott’s Panbio Rapid Antigen Test Receives CE Mark for Mass COVID-19 Screening

    Shots: Abbott received a CE mark for asymptomatic testing and self-swabbing using its Panbio COVID-19 Ag test to detect SARS-CoV-2. Abbott has shipped 200M test to 120 countries globally The test is approved with a patient-friendly and minimally invasive nasal swab, i.e. patients can self-administer sample collection under an HCP’s supervision and delivers results in […]

  • Boston Scientific to Acquire Preventice for ~$1.2B

    Shots: Boston Scientific to acquire Preventice for ~$1.2B including $925M as up front, up to an additional $300M as commercial milestones. However, Boston Scientific has built up a 22% stake in Preventice, which is expected to lower up front to $720M upfront & $230 million in milestone respectively The acquisition is expected to be close […]

  • Qiagen’s PCR Tests Demonstrate Effectiveness in Detecting Mutations in SARS-CoV-2 Virus

    Shots: Qiagen’s QIAstat-Dx and NeuMoDx tests remain accurate & effective in detecting SARS-CoV-2 infections The company started cross-checking variants in May’2020 & assessed the tests against genetic mutations of the virus uploaded to the GISAID and GenBank public databases. Qiagen will continue to conduct assessments on a biweekly basis Variants with potentially increased transmissibility include […]

  • Haemonetics to Acquire Cardiva Medical for ~$510M

    Shots: Cardiva to receive $475M up front and up to an additional ~$35M in contingent consideration based on sales growth. The transaction is expected to be completed in Q1’21 The acquisition expands Haemonetics’ blood transfusion and loss management offerings and enhance its penetration into the large and growing interventional cardiology and electrophysiology markets Cardiva’s portfolio […]

  • Thermo Fisher to Acquire Mesa Biotech for $450M

    Shots: Thermo Fisher acquires Mesa Biotech for $450M in cash. Mesa Biotech will receive an additional ~$100M in cash on the completion of milestones while the transaction is expected to be completed in Q1’21 Mesa has developed & commercialized a PCR-based rapid POC testing platform for detecting infectious diseases. Messa’s technology inflates the availability of […]

  • Hologic to Acquire Biotheranostics for ~$230M

    Shots: Hologic acquires Biotheranostics to speed up its entry in the oncology market. The transaction is expected to be completed in Feb’2021 The acquisition will provide Hologic access to Biotheranostics’ CLIA lab and will aid in accelerating market development for novel tests The acquisition allows Hologic to leverage commercial capabilities and expertise in molecular diagnostics […]

  • Stryker Acquires OrthoSensor and its Knee Surgery Sensor Technology

    Shots: Stryker acquires OrthoSensor and its Verasense intraoperative sensor tech, enhancing the ortho giant’s Mako robots The acquisition allows Stryker to empower surgeons with comprehensive data-driven solutions. The sensor tech will boost Mako surgical robotics systems, enhancing workflow through one complete data-driven feedback mechanism Moreover, OrthoSensor’s MotionSense remote patient monitoring wearables and mobile application combined […]

  • Oura Ring Monitors Body Temperature and Identify Early COVID-19 Symptoms

    Shots: Early results from TemPredict study conducted at the University of California unveils that the Oura Ring’s continuous temperature monitoring could detect fevers before patients began to experience symptoms, suggesting that the technology could function as an early warning system for COVID-19 The ring measures health parameters, including heart rate, activity levels, temperature, and respiratory […]

  • Sorrento Reports Submission of MAA to COFEPRIS for COVI-STIX Rapid Detection Test

    Shots. The company has submitted MAA to COFEPRIS (the health regulatory authority for Mexico) for its COVI-STIX rapid diagnostic test to detect SARS-CoV-2 virus nucleocapsid antigen in nasal samples of patients The test provides results in 15min. with positive detection as quickly as 2min for patient samples with high viral load. Additionally, Sorrento is also […]

  • Biocon has Launched Tacrolimus Capsules in the US

    Shots: The launch of Tacrolimus capsules follows the approval of the US FDA in Nov’20 and emphasizes Biocon activity to make affordable healthcare accessible Tacrolimus is particularly effective in treating patients of renal transplant Tacrolimus, a calcineurin inhibitor immunosuppressant used to treat organ transplant patients, reduces the body’s ability to reject a transplanted organ Click […]

  • Biocon Launches Tacrolimus Capsules in the US

    Shots: The launch of Tacrolimus capsules follows from approval of US FDA in Nov. 2020 and underscores Biocon relentless pursuit to make affordable healthcare accessible It has particularly effective in treating patients of renal transplant for more than 2 decades Tacrolimus, a calcineurin inhibitor, is an immunosuppressant used in the treatment of organ transplant patients, […]

  • Philips to Acquire BioTelemetry for ~$2.8B

    Shots: Philips to acquire all outstanding shares of BioTelemetry and its wearable heart-tracking devices for $72/ share in cash with a 16.5 % premium to a closing price of BioTelemetry on Dec 17, 2020, making a total value ~$2.8B. The transaction is expected to be completed in Q1’21 The acquisition complements Philips’ cardiac care portfolio […]

  • NOWDiagnostics Receives CE Mark for its ADEXUSDx COVID-19 Antibody Fingerstick Test

    Shots: NOWDiagnostics has received a CE mark approval for its ADEXUSDx COVID-19 Ab fingerstick test across 28 countries in the EU. The test first received CE mark for use in moderate/complex laboratory settings on July 28, 2020 By measuring the presence of SARS-CoV-2 Abs, the ADEXUSDx COVID-19 Test provides precise and reliable results in 15 […]

  • Abbott’s COVID-19 IgG Quantitative Antibody Blood Test Receives CE Mark

    Shots: Abbott received CE Mark for its new quantitative SARS-CoV-2 IgG lab-based serology test. The test measures levels of IgG Abs to help in the evaluation of a person’s immune response The study to determines the clinical performance of Abbott’s SARS-CoV-2 IgG II Quant test on its Alinity i instrument showed that it had 99.60% […]

  • Roche Launches Elecsys SARS-CoV-2 Antigen Test to Support High-Volume COVID-19 Testing

    Shots: Roche has launched Elecsys SARS-CoV-2 Ag test as an aid in the diagnosis of SARS-CoV-2 infections, in the markets accepting the CE Mark. Additionally, Roche has also filed a EUA to the US FDA The test showed 94.5% sensitivity across 200 PCR confirmed symptomatic individuals & 99.9% specificity across 2747 PCR negative symptomatic & […]

  • Roche Collaborate with Moderna to include SARS-CoV-2 Ab Test in COVID-19 Vaccine Trials

    Shots: Roche allied with Moderna to utilize the Elecsys anti-SARS-CoV-2 S Ab test in mRNA-1273 study. The collaboration will facilitate the quantitative measurement of SARS-CoV-2 Abs and help to establish a correlation b/w vaccine-induced protection and levels of anti-RBD Abs The alliance follows US FDA’s EUA for the Elecsys anti-SARS-CoV-2 S Ab test. Moderna’s vaccine […]

  • Roche Collaborate with Moderna to include SARS-CoV-2 Ab Test in COVID-19 Vaccine Trials

    Shots: Roche allied with Moderna to utilize the Elecsys anti-SARS-CoV-2 S Ab test in mRNA-1273 study. The collaboration will facilitate the quantitative measurement of SARS-CoV-2 Abs and help to establish a correlation b/w vaccine-induced protection and levels of anti-RBD Abs The alliance follows US FDA’s EUA for the Elecsys anti-SARS-CoV-2 S Ab test. Moderna’s vaccine […]

  • Qiagen Launches QuantiFERON SARS-CoV-2 RUO Solution for COVID-19

    Shots: Qiagen launches QuantiFERON SARS-CoV-2 RUO solution that detects T-cell responses of the human immune system to the pathogen for COVID-19 Studies suggested that T-cell response to SARS-CoV-2 declines more slowly than Ab response presenting benefits to a researcher who wants to push beyond the existing detection of active infections to screen for potential courses […]

  • Creating Future of MedTech Industry with Artificial Intelligence

    Artificial Intelligence is a breakthrough technology and has been used tremendously in this data-driven age, leading to a leap forward in the MedTech industry. Artificial Intelligence enrolls the use of advanced machine learning algorithms and fulfills the job, which has been tackled by humans for ages. It has flourished extensively over the past years owing […]

  • Exactech Acquires Muvr and it’s Digital Health Tech for Orthopedic Practices

    Shots: Exactech has acquired intelligent patient wearables and digital communication solutions maker Muvr Labs to expand its Active Intelligence platform of smart technologies portfolio The Muvr platform includes patient wearables, mobile device applications, and chatbot texting, allowing the surgeons to remotely monitor patient recovery Exactech expects a pilot launch of the Muvr technology in early […]

  • Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

    Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology sustains performance for ~14days, providing trends, insights & actionable data […]

  • BASE10 Collaborates with DNA Link to Support Authorization of COVID-19 IgG Antibody Test at the Point of Care

    Shots: The companies collaborated to evaluate the usability of DNA Link’s AccuFind COVID-19 IgG antibody test in a healthcare setting The study intends to expand access to antibody testing outside of laboratory settings The companies plan to launch the study in Dec’2020 Click here ­to­ read full press release/ article | Ref: PRNewswire | Image: Base 10 genetics The post […]

  • CoSara Receives CDSCO’s Approval for its Saragene COVID-19 2-Gene Multiplex Test

    Shots: Co-Diagnostics’ JV CoSara has received CDSCO’s clearance to manufacture and sell its Saragene COVID-19 2-gene multiplex RT-PCR test as an IVD, intended for the qualitative detection of the SARS-CoV-2 virus The kit leverages CoPrimer technology & is based on a test originally designed by Co-Diagnostics, who secured CE marking for its Logix Smart SARS-CoV-2 […]

  • CorticoMetrics’s THINQ Receives the US FDA’s 510(k) Clearance for MRI Brain Volumetric Reporting

    Shots: The US FDA has granted 510(k) clearance for CorticoMetrics’ AI-based software, THINQ, for MRI brain volumetric reporting. The software can provide radiologists & neurologists with quantitative to improve assessment of neurological disorders The software can automatically segment T1-weighted MRI brain image, providing volumetric measurements & visualisations of 30 critical brain structures and compares the […]

  • Microsoft Collaborates with Twist and Illumina to Advance Data Storage in DNA

    Shots: Microsoft enters collaboration with Illumina, Twist, and Western Digital to establish a roadmap for the industry towards the wider use of DNA data storage. These companies are the founding members of the alliance Ten additional technology leaders join founding members to together advance industry roadmap, set the stage for widespread adoption of new long-term […]

  • Qiagen Launches Portable Digital SARS-CoV-2 Antigen Test in the US

    Shots: Qiagen has initiated the commercialization of the portable digital QIAreach SARS-CoV-2 antigen test in the US that can be used by laboratories to detect active infections in 2-15mins. The test provides a higher throughput testing for SARS-CoV-2 antigen by processing up to 8 tests/ hub. The digital results do not need subjective interpretation and […]

  • Medtronic Launches InPen Integrated with CGM Data for People with Diabetes on MDI

    Shots: The integration of real-time CGM data into the smart insulin pen app follows the acquisition of Companion Medical’s InPen to the Medtronic portfolio, as of Sept’2020 The integrated system provides real-time glucose readings alongside insulin dose information giving users everything they need to manage their diabetes through a single smartphone app InPen is the […]

  • Qiagen Collaborate with TScan to Develop T Cell-Based COVID-19 Test

    Shots: TScan signs exclusive research and option to license agreement with Qiagen to develop T cell-based laboratory tests for detecting prior exposure to the SARS-CoV-2 Qiagen gets an option to license the rights and IP for several of TScan discovered immunodominant T cell targets, associated sequences and relevant data for the development and commercialization of […]

  • Abbott Launches IonicRF Generator for Patients with Chronic Pain in the US

    Shots: Abbott has launched the IonicRF Generator, which is used to deliver a non-surgical, minimally invasive treatment for the management of pain in the nervous system Radiofrequency ablation uses an electric current to heat up a small area of nerve tissue to stop it from sending pain signals. Studies showed that pain relief following a […]

  • Coloplast Acquires Nine Continents Medical

    Shots: Coloplast has acquired implantable tibial nerve stimulation (ITNS) treatment developer Nine Continents Medical for $145M upfront and an additional contingent milestone. ITNS is developed for overactive bladder (OAB) Coloplast expected to initiate clinical studies of ITNS in 2021 with the goal to obtain pre-market approval for a Class III device in the US and […]

  • Abbott to Launch its Cardiac Mapping Platform in Europe and Australia

    Shots: The company has received CE mark in EU and approval in Australia for its new EnSite X EP system which offers the option to navigate the cardiac anatomy in two different ways on one platform. The system can create a 3D model of the patient’s cardiac anatomy in real time and will enable physicians […]

  • Exact Sciences to Acquire Thrive Earlier Detection for ~$2.15B

    Shots: Exact Sciences to acquire Thrive in all cash & stock transaction for ~2.15B out of which $1.7B would be payable at closing, consisting of 65% in Exact Sciences common stock and 35% in cash along with ~$450M as milestones related to the development and commercialization of a blood-based, multi-cancer screening test. The transaction is […]

  • StageBio Acquires TPL Path Labs to Expand its Footprints Globally

    Shots: StageBio and TPL Path Labs offers an expanded array of histopathology, molecular pathology, and related solutions to biopharma, medical device and academic researchers across the US, EU, and other countries The acquisition expands StageBio’s pre/ clinical laboratory resources, GLP/GCLP-compliant lab facility and staff in Germany tits existing 6 GLP-compliant lab facilities and 2 GLP […]

  • Roche Collaborates with Genesis Therapeutics for AI-Driven Drug Discovery

    Shots: Genesis to receive an up front and is eligible to receive pre/ clinical and regulatory milestones along with royalties on sales of approved drugs emerges from the collaboration The collaboration leverages Genesis’ graph machine learning and drug discovery expertise to identify drug candidates for therapeutic targets across multiple disease areas Genesis has developed Dynamic […]

  • Genentech Collaborates with Imbio to Develop Imaging Diagnostics for Lung Diseases

    Shots: The agreement leverages Imbio’s technical, regulatory & commercial expertise to build medical imaging AI technology for use in research, clinical trials & clinical practice The focus of the agreement is to develop quantitative imaging diagnostics for lung diseases and to bring unique solutions for pulmonary imaging. The collaboration integrates Imbio’s expertise in imaging biomarkers […]

  • Eli Lilly Collaborates with Dexcom for Diabetes Management

    Shots: The companies will partner to promote Lyumjev (insulin lispro-aabc injection, 100 & 200 units/mL) with Dexcom G6 CGM to aid HCPs in the US for the management of diabetes, including giving visibility to the benefits of a new mealtime insulin HCPs treating T1D & T2D will be able to assess their patient’s glucose levels […]

  • Qiagen to Launch Viral RNA Epidemiology Test for COVID-19 and Other RNA Viruses

    Shots: Qiagen to launch the QIAprep&amp Viral RNA UM Kit, designed to simplify and accelerate PCR swab analysis and remove key testing bottlenecks for Covid-19 and other RNA viruses The kit combines a liquid-based sample preparation step completed in the only 2min. with real-time PCR detection in a streamlined workflow that can be automated with […]

  • Philips to Acquire Intact Vascular for $360M

    Shots: Philips will acquire Intact Vascular for $275M up front and deferred payments of $85M upon completion of the transaction. The transaction is expected to be completed in Q3’20 The collaboration will expand Philips’ image-guided therapy portfolio with the addition of Intact Vascular’s Tack endovascular system, that reinforces standard and drug-coated balloon PAD treatment results […]

  • Philips and B. Braun’s Onvision Needle Tip Tracking Technology Receive the US FDA’s 510 (k) Clearance for Regional Anesthesia

    Shots: Onvision needle tip tracking technology will be exclusively available on the latest version of the B. Braun and Philips’ Xperius ultrasound system together with the Stimuplex Onvision needle, empowering anesthesiologists to embrace regional anesthesia as a viable and effective alternative to general anesthesia. It allows anesthesiologists the confidence to accurately position the needle tip […]

  • Qiagen to Launch Digital Test for Detecting SARS-CoV-2 Antibodies in the US

    Shots: Qiagen reports the launch of the Access Anti-SARS-CoV-2 Total test that runs on a portable device and provides accurate results on Total Ig Abs (IgA, IgM, IgG) in 10mins. The device can process up to 8 samples simultaneously or up to 32 tests/hour The test was developed in collaboration with Ellume, following the US […]

  • Bionano Genomics Acquires Lineagen to Facilitate the Clinical Adoption of Saphyr for Digital Cytogenetics

    Shots: Lineagen to receive $9.6M consisting of 6,167,510 shares of Bionano’s common stock, ~ $1.7M in cash and assumption of ~$2.9M in liabilities. The acquisition complements Binano by adding leading cytogeneticists, genetic counselors, laboratory operations and billing experts, clinical commercialization experts, and payor contracts The acquisition expands Bionano’s Saphyr genome imaging platform by adding Lineagen’s […]

  • Qiagen Launches QIAseq SARS-CoV-2 Primer Panel for Tracking COVID-19 Mutations and Strains

    Shots: Qiagen’s QIAseq SARS-CoV-2 primer panel provides optimized, single-day workflows to prepare libraries for sequencing as researchers use NGS to track changes in the viral genome The two-step process uses advanced QIAseq technologies to conduct reverse transcription and cDNA synthesis from a viral RNA sample, then generate libraries compatible with Illumina sequencing platforms The solution […]

  • Fitbit Report Results of its COVID-19 Study for Early Detection of Diseases

    Shots: In May’2020, Fitbit has launched its COVID-19 study to build an algorithm that detects COVID-19 before symptoms starts. The study has enrolled 1000+ positive patients across the US and Canada is now delivering its first, preliminary results 90 days later The study demonstrated that its devices could detect ~50% of COVID-19 cases one day […]

  • Alphabet’s Verily Establishes CLIA-Certified Lab Focusing on COVID-19 Testing

    Shots: Verily has expedite the COVID-19 testing with a new lab-based at South San Francisco. The lab will use the technology from Thermo Fisher Scientific’s‎ TaqPath test kit that has received the US FDA’s EUA to test COVID-19 Verily has submitted a EUA for an adaptation of the TaqPath test to use in testing pooled […]

  • Medtronic to Acquire Companion Medical for Adding Smart Insulin Pen to its Diabetes Unit

    Shots: The acquisition will expand Medtronic’s capabilities to serve people using multiple daily injections (MDI) to manage diabetes with the addition of Companion Medical’s InPen to Medtronic’s portfolio. The acquisition is expected to be closed within 1-2mos. Medtronic will advance the automation of insights and dosing capabilities to reduce the burden of diabetic patients. Additionally, […]

  • Olympus to Acquire Arc Medical Design for Expanding its Product Portfolio

    Shots: The acquisition will expand Olympus’ offerings in GI therapeutic devices and the development of advanced colonoscopy tools with the aim of improving early detection and treatment of CRC Olympus will obtain full rights to Arc Medical Design’s medical products and will convert its current exclusive distribution rights of Endocuff Vision to a full acquisition […]

  • AstraZeneca Collaborates with Eko to Advance the Digital Health Tools for the Diagnosis of CV Diseases

    Shots: The two companies collaborated to facilitate the development of digital health tools for the earlier screening of cardiovascular diseases, including HF AstraZeneca and Eko will accelerate the development of Eko algorithms, enhancing clinical trials with Eko technology, and potentially building new HF detection solutions. The agreement allows the companies to harness the potential to […]

  • Siemens Healthineers to Acquire Varian for $16.4B

    Shots: Siemens Healthineers to acquire Varian in an all-cash transaction, at a price of $177.50/ share with 42% to the 30-day volume-weighted average closing price of Varian’s common stock as of July 31, 2020, making a total deal value ~$16.4B The transaction is expected to be closed in H1’21. The combined company will offer an […]

  • Zebra Medical Receives the US FDA’s Approval for its HealthMammo Mammography Tool

    Shots: The US FDA has granted 510 (k) clearance to HealthMammo for boosting early detection of breast cancer in mammograms The tool utilizes the AI to prioritize and identify suspicious mammograms and is automatically sent to Zebra’s platform, where it gets processed and analyzed for suspected breast lesions. The HealthMammo product then returns its result […]

  • Roche Signs RWD Collaboration with PicnicHealth to Create Personalized Treatment for Patients with Multiple Sclerosis

    Shots: The real-world evidence partnership will allow the Roche to access PicnicHealth’s set of de-identified patient records to gain insights on certain diseases and treatments The collaboration will initially focus on MS and may be extended to support Huntington’s disease (HD), paroxysmal nocturnal hemoglobinuria (PNH), and hemophilia The companies signed a multi-year collaboration that combines […]